newsfilter
← Latest News
GlobeNewswire·

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Strengthened financial position resulting from recently announced MARGENZA® transaction and previously announced receipt of milestone payment from Incyte related to advancement of ZYNYZ®ADAM9-directed ADC